Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03637348 · ClinicalTrials.gov registry record · NA
Effect of TrueTear Corneal Surface Imaging
A NA study, sponsored by Price Vision Group.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT03637348 is a NA study that has completed, run by Price Vision Group. The registered enrollment target is 45 participants.
The verdict
NCT03637348, a NA study, has completed, sponsored by Price Vision Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
This study will evaluate the utility of TrueTear™ to improve anterior corneal surface imaging quality before cataract surgery, refractive lens exchange, or laser refractive surgery.
Interventions
- DEVICE TrueTear
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2018-08-13 |
| Est. Completion | 2019-07-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03637348
The ClinicalTrials.gov registry entry for NCT03637348 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Price Vision Group, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TrueTear is the first listed.
NCT03637348 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03637348 about?
NCT03637348 is a clinical study titled "Effect of TrueTear Corneal Surface Imaging". This study will evaluate the utility of TrueTear™ to improve anterior corneal surface imaging quality before cataract surgery, refractive lens exchange, or laser refractive surgery.
What is the current status of trial NCT03637348?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2018-08-13. Estimated completion is 2019-07-08.
What interventions are being tested in trial NCT03637348?
The interventions under investigation include: TrueTear (DEVICE).
Who is sponsoring clinical trial NCT03637348?
This trial is sponsored by Price Vision Group, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.